Open access · OA
via Europe PMC
Circulating immunometabolic signatures of sarcopenia at high altitude.
The journal of nutrition, health & aging · 2026
Abstract
This study examines circulating immunometabolic signatures associated with sarcopenia in high-altitude populations. Published in 2026.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.jnha.2026.100934
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
LK., C. (2026). Circulating immunometabolic signatures of sarcopenia at high altitude. <em>The journal of nutrition, health & aging</em>. https://doi.org/10.1016/j.jnha.2026.100934
Vancouver
LK. C. Circulating immunometabolic signatures of sarcopenia at high altitude. The journal of nutrition, health & aging. 2026. doi:10.1016/j.jnha.2026.100934.
BibTeX
@article{chen2026Circul,
title = {Circulating immunometabolic signatures of sarcopenia at high altitude.},
author = {Chen LK.},
journal = {The journal of nutrition, health & aging},
year = {2026},
doi = {10.1016/j.jnha.2026.100934},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The journal of nutrition, health & aging 2026
Open access · OA
Corrigendum to "Circulating immunometabolic markers associated with sarcopenia and muscle strength at high altitude: An integrated multi-omics study" [J Nutr Health Aging, 30 (2026) 100904].
Journal of the American Medical Directors Association 2014
Citation only
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
First Affiliated Hospital of Wenzhou Medical University 2022
Open access · US-GOV
The Effect of Sarcopenia on the Efficacy and Prognosis of HCC Treated With Lenvatinib and Anti-PD-1 Treatment
Bone 2015
Preprint · OA
Osteoporosis and sarcopenia in older age
Wiener Medizinische Wochenschrift 2018
Citation only
Sarcopenia
Clinics in Geriatric Medicine 2010
Citation only